Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

All aboard! Saskatoon’s ‘iconic’ Prairie Lily will return this spring

April 2, 2026

Rally House Expands CoMo Footprint with Third Store

April 2, 2026

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

April 2, 2026

HUBG SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub Group

April 2, 2026

Centenary Anniversary: Presenting the “Legion 100” tulip

April 2, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Analysis on China’s $9+ Billion IVF Market, 2024-2030, Featuring Vitrolife, Cloudnine, Nova IVI Fertility, Monash IVF, Maria Fertility Hospital, Bangkok Fertility Center, and EMD Serono
Press Release

Analysis on China’s $9+ Billion IVF Market, 2024-2030, Featuring Vitrolife, Cloudnine, Nova IVI Fertility, Monash IVF, Maria Fertility Hospital, Bangkok Fertility Center, and EMD Serono

By News RoomMarch 1, 20243 Mins Read
Analysis on China’s + Billion IVF Market, 2024-2030, Featuring Vitrolife, Cloudnine, Nova IVI Fertility, Monash IVF, Maria Fertility Hospital, Bangkok Fertility Center, and EMD Serono
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, March 01, 2024 (GLOBE NEWSWIRE) — The “China In-Vitro Fertilization Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis” report has been added to ResearchAndMarkets.com’s offering.

This report provides an in-depth analysis of the current trends, growth drivers, and obstacles impacting the China In-Vitro Fertilization (IVF) market. This research study sheds light on the potential growth expected between 2024 and 2030, examining various segments including treatment types, instruments, procedures, and end-users.

China’s Commitment to Expanding IVF Facilities Signals Market Growth

A key insight from the report highlights the Chinese government’s promise to establish extensive IVF facilities to accommodate increasing demand by 2025. With over half a million IVF cycles annually yielding approximately 300,000 births, China’s investment in reproductive health services is a hallmark example for countries grappling with similar demographic challenges. These initiatives are crucial in assisting families looking to expand, and the market’s reaction to these measures is expected to be robust.

Market Trends Shaping the In-Vitro Fertilization Industry in China

  • Economic advancement and lifestyle shifts lead to a significant market for IVF procedures, with a notable emphasis on donor egg treatments.
  • Disposable devices in IVF practices are gaining traction, owing to their convenience and heightened standards for infection control.
  • ICSI IVF is projected to dominate the procedural aspect of the market, addressing male infertility more effectively.
  • Fertility clinics emerge as the prevalent end-users in the market, aligning with the specialized care and advanced treatment preferences.

Forecasted Growth underpinned by Economic Development and Cultural Factors

The anticipated compound annual growth rate (CAGR) of 7.72% between 2024-2030 signifies the dynamic expansion of the China IVF market, largely influenced by the economic progression, the shift towards later-in-life parenthood, and the supportive healthcare landscape. The trend of delayed motherhood, prevalent in urbanized regions, plays a significant role in driving the need for assisted reproductive technologies.

Key Findings on IVF Market Segmentation

The segmentation of the IVF market, detailed within the report, reveals a comprehensive breakdown as follows:

  1. Fresh Embryo
  2. Frozen Embryo
  3. Donor Egg
  4. Others

By instruments, the segmentation is categorized as:

  1. Culture Media
  2. Disposable Devices
  3. Capital Equipment

Regarding procedures, the breakdown includes:

  1. ICSI IVF
  2. Non-ICSI IVF
  3. IUI

Discerning the end-users, the analysis covers:

  1. Fertility Clinics
  2. Hospitals
  3. Others

Industry Leaders Spearheading the China IVF Market

The report delivers an objective review of the competitive landscape, featuring comprehensive profiles on leaders in the IVF space, their developmental milestones, and revenue analyses. These key players are charting the path forward with their pioneering services and technologies in IVF treatments.
Through meticulous market examination, insightful trends analysis, and strategic forecasts, this report emerges as a critical resource for stakeholders in the China IVF market, providing the data needed to understand the trajectory and opportunities in this burgeoning sector.

Key Attributes

Report Attribute Details
No. of Pages 105
Forecast Period 2023-2030
Estimated Market Value (USD) in 2023 $5.37 Billion
Forecasted Market Value (USD) by 2030 $9.04 Billion
Compound Annual Growth Rate 7.7%
Regions Covered China

Companies Mentioned

  • Vitrolife
  • Cloudnine
  • Nova IVI Fertility
  • Monash IVF
  • Maria Fertility Hospital
  • Bangkok Fertility Center
  • EMD Serono, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/dol4a4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Chinese In-Vitro Fertilization Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Rally House Expands CoMo Footprint with Third Store

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

HUBG SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub Group

Centenary Anniversary: Presenting the “Legion 100” tulip

SMCI SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Super Micro (SMCI) Investors of Securities Class Action Deadline on May 26, 2026

Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month

7th Avenue Opens New Showroom at Westfield Galleria at Roseville, Bringing Its Luxury Showroom Experience to Sacramento

Overland AI Completes Successful Deployment with 3rd Brigade, 82nd Airborne Division at JRTC

Cumulus Media’s Westwood One Presents Exclusive Full-Court Audio Coverage of the 2026 NCAA® Division I Men’s and Women’s Basketball Final Four® and National Championship Games on Multiple Platforms

Editors Picks

Rally House Expands CoMo Footprint with Third Store

April 2, 2026

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

April 2, 2026

HUBG SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub Group

April 2, 2026

Centenary Anniversary: Presenting the “Legion 100” tulip

April 2, 2026

Latest News

PSA: Anyone with a link can view your Granola notes by default

April 2, 2026

SMCI SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Super Micro (SMCI) Investors of Securities Class Action Deadline on May 26, 2026

April 2, 2026

Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month

April 2, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version